AceCann is a medical cannabis company dedicated to the organic cultivation, processing and extraction of premium medical cannabis products for the European market.
AceCann has raised €13M across 1 funding round from 6 investors, most recently a round in Oct 2021. Based in Lisbon, Portugal; active in Agritech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-12 | Other | €13M |
| Casa Verde,Chris Mayle,Frank Cid,Lince Capital,Marc Gare,Sebastian de la Rosa |
| View deal → |
